1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow DV281: new trials by email Literature Review of DV281 trials Research Report on DV281
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC DV281, Breath Actuated Nebulizer, DV281 (RP2D) - Advanced Non Small Cell Lung Cancer | Phase 1 | Completed | Dynavax Technologies Corporation | 26 | 2017-09-20 | 2020-06-17 |
Lung Neoplasms (1) · Neoplasms (1)
Dynavax Technologies Corporation (1)
United States (1)
Edward Garon, MD (1)